According to the latest research by the National Institutes of Health (NIH), chemical-based hair relaxers like Dark and Lovely lead to the risk of uterine cancer and several hormone-related health disorders. The globally known brand L’Oreal has been the manufacturer of Dark and Lovely. As per the new evidences out, hundreds of users have filed product liability lawsuits against the premium brand along with other cosmetic companies.
The product has been allegedly reported to cause uterine cancer and other diseases in women’s bodies. According to victims, L’Oréal USA and its subsidiary SoftSheen-Carson, which manufactures Dark and Lovely, have failed to inform consumers about the risks posed by endocrine-disrupting chemicals in their products since 1972.
The brand has been popular among black and brown women, offering a range of products, including chemical hair relaxers, dyes, and creams. Other brands, such as Revlon and Strength of Nature, have also been linked to this lawsuit. Women have been using the products for generations, driven by their growing popularity. The manufacturers deny the allegations and claim their products are safe for use.
However, studies have shown a link between hair relaxer use and various types of cancer. Though the allegations have not yet been proved, the L’Oréal hair relaxer lawsuit is on. The attorneys at People for Law are fighting this cause in courts across the U.S., backed by strong legal support and strategies. If you have any concerns regarding this matter, connect with our expert team of attorneys.
L’Oreal Hair Relaxer Lawsuit Payout & Settlement Updates (June 2026)
L’Oréal is one of the world’s largest cosmetic manufacturers, valued at around $300 billion, with its headquarters in France. The size and scope of the brand are why we see so many hair relaxer lawsuit ads. In the early 1900s, the brand was founded by a French chemist with a few employees. Today, the company has more than 500 brands and 85,000 employees worldwide. L’Oréal USA Inc. is the company based in New York City, with its subsidiaries in the U.S. and South America.
Who is Eligible to file a hair relaxer lawsuit?
Women who were diagnosed with particular cancers or medical conditions due to the use of chemical hair relaxer products could be eligible to file a lawsuit. Actual eligibility will be based on multiple factors about the individual, such as the type of diagnosis they have, history of product use, and the amount of evidence available to support a claim. By speaking with an attorney, specific case details can be used to determine whether the claim qualifies for filing.
History of Product Use:
Most lawsuits revolve around women who used chemical hair relaxers on a routine basis and over a long duration of time. There is no defined minimum time requirement; however, women who have filed claims often state that they used relaxer products for many years, and in some cases for decades, before diagnosis. The regularity and longevity of the product’s use might also significantly factor into determining liability for the alleged medical condition.
Diagnosis Requirements:
For someone to be eligible to file a hair relaxer lawsuit, the individual must typically have received a diagnosis of a condition allegedly linked to the use of a chemical hair relaxer. Typical conditions for filing include:
- Uterine Cancer
- Endometrial cancer
- Ovarian Cancer
- Uterine Fibroids
- Endometriosis (sometimes)
Medical records and evidence of such a diagnosis will likely be needed to receive compensation for the claim.
Statute of Limitations:
There are statutory deadlines in every state across the United States within which individuals have the right to file a lawsuit. Each state differs on these deadlines; however, filing before these deadlines expires is essential to avoid losing one’s right to sue.
Proof Requirements:
When filing a lawsuit, evidence must be presented, including both the use of the product and the receipt of a qualifying diagnosis. It is highly beneficial to have the following evidence:
- Medical records and pathology reports
- Cancer records and diagnoses
- Treatment and hospital records
- Prescription history
- Product purchasing history, where available
- Product photos or packaging
- Salon records
- Testimonies of the product’s use over time
MDL / Lawsuit Update
Latest L’Oréal Hair Relaxer Lawsuit Updates
The L’Oréal hair relaxer litigation already expanded even in 2026 as numerous women pursue claims claiming that the chemical hair relaxer product already increased their risk of developing uterine, endometrial cancers, and ovarian cancer. The lawsuit has already been consolidated into a federal multidistrict litigation (MDL), enabling the court to manage numerous common issues, including scientific testimony and pretrial proceedings, more effectively.
As new cases continue to be filed every month and bellwether trial preparation already underway, the litigation remains an active mass tort even in the USA.
Current MDL Status in 2026
The hair relaxer lawsuits already fall under MDL no. 3060, also known as Hair relaxer marketing, sales practices, and product liability litigation.
The cases are already overseen by Judge Mary M. Rowland, even in the US District Court for the Northern District of Illinois.
MDL has become the largest active federal mass tort proceeding, reflecting the growing number of women who allege injuries that are already linked to chemical hair straightening products.
Statistics:
- MDL Number: 3060
- Federal Court: Northern District of Illinois
- Presiding Judge: Mary M Rowland
As of 2026, around 11,000 active lawsuits are pending. It is already ranked among the largest active MDLs even in the federal court system.
Number of Lawsuits Filed So Far
Throughout 2025 and 2026, the number of hair relaxer lawsuits has risen steadily. While the court filing indicates that more than 11,400 plaintiffs have joined the litigation, hundreds of new claims are being added regularly.
Plaintiffs allege that they developed uterine cancer, ovarian cancer, and other reproductive health complications just after years of using chemical hair relaxer products that companies manufacture. They consist of L’Oreal, SoftSheen-Carson, and Strength of Nature.
Statistics:
- 11,195 pending lawsuits as reported in February 2026
- 11,440 pending lawsuits as reported in March 2026
- In April, there were 11,526 pending lawsuits
In the MDL docket, around 15,500 filings have already been recorded as of the creation of the Bellwether Trial Timeline.
Bellwether Trials
Designed to test evidence and aid both sides in evaluating the potential value of the future settlements. It is Judge Rowland who established a full-fledged bellwether process that consists of extensive discovery, case-selection procedures, and expert testimony.
The court has already narrowed the pool of potential trial cases and even selected bellwether plaintiffs that are moving through unique advanced discovery stages. While some observers previously expected trials in late 2026, many legal analysts now believe the first bellwether trials are more likely to begin in 2027.
Statistics:
- 32 cases initially selected for the bellwether pool
- 10 cases advanced for further bellwether consideration
- 3 initial bellwether cases reportedly selected by the court
Recent Court Decisions
The direction of the hair relaxer litigation has well shaped the significant ruling. At the same time, Rowland enabled major claims against the manufacturers to proceed by rejecting attempts, even by several defendants, to dismiss the entire lawsuits.
Statistics
- 1,500 active cases currently under MDL management
- 10 bellwether candidates selected for advanced review
- Daubert expert challenges are scheduled as part of the scientific evidence process
- Ongoing monthly growth of hundreds of new lawsuits
L’Oral Hair Relaxer Products Included in Lawsuits
Several high-profile hair relaxer and straightening product manufacturers have been named in the ongoing MDL 3060 litigation. Plaintiffs claim these products contained chemicals such as endocrine disruptors that increased the risk of uterine cancer, ovarian cancer, endometrial cancer, and other reproductive health disorders. They claim the companies marketed and sold these products for decades, and thus must have been aware of the potential long-term health risks to the millions of women using them. As of 2026, more than 11,500 lawsuits have been filed in federal court involving hair relaxer products sold by, among others, L’Oréall, SoftSheen-Carson, Strength of Nature, Namaste Laboratories, and Godrej.
Dark & Lovely
One of the more frequently named hair relaxer brands in lawsuits is Dark & Lovely. This SoftSheen-Carson, a subsidiary of the L’Oreal brand, has been sold to Black women for decades, and plaintiffs argue that prolonged usage has led to hormone-related cancers and reproductive diseases.
Optimum
Another SoftSheen-Carson, L’Oréal-brand relaxer found in many suits is Optimum. Marketed as a conditioning, scalp-friendly relaxer system, Optimum products are alleged to have contained harmful endocrine disruptors. Many of the suits claim the plaintiffs used this product regularly over several years before developing cancer.
SoftSheen-Carson
As the company that produces both the Optimum and Dark & Lovely lines, SoftSheen-Carson has been included in thousands of claims. Court documents indicate that the company has been named in the majority of cases in the MDL, with plaintiffs arguing that SoftSheen-Carson products are linked to elevated cancer risks despite being marketed as safe.
Motions
Motions hair relaxers, which were formerly associated with Unilever, have also been named in lawsuits over claims that the use of their products is linked to an increased risk of uterine and ovarian cancer. The brand is among the latest to be included in the extensive list of products under legal scrutiny.
ORS (Organic Root Stimulator)
Sold under the popular brand name ORS, these Olive Oil relaxers have been named in many hair relaxer suits. Produced by companies associated with Dabur, the brand was marketed for its use of natural products; however, plaintiffs believe the chemicals in the products may still pose a risk to users’ reproductive health.
Just For Me
Marketed specifically to children, particularly young girls, this relaxer brand is a focal point in many lawsuits. Parents and other attorneys argue that these products place children at an elevated risk over a lifetime of usage, citing evidence of young users applying them before puberty.
African Pride
This hair relaxer brand, linked to Godrej-affiliated companies, has also been cited as being among those that increase a user’s risk of developing cancer as a result of its alleged endocrine disrupting chemicals.
Scientific Study Breakdown
The NIH Sister Study:
The NIH Sister Study, a major research effort involving over 33,000 participants, was published in 2022 and indicated that increased usage of chemical hair straightening products may be linked to a higher risk of uterine cancer. It has since become one of the most cited studies in the ongoing hair relaxer litigation.
Cancer Statistics:
Researchers suggested that those women who regularly use chemical hair straighteners face over double the risk of developing uterine cancer than non-users of such products. Although uterine cancer is a comparatively rare type of cancer, it has drawn considerable public health interest.
Endocrine Disruptors:
It is thought that certain chemicals present in hair straighteners act as endocrine disruptors; that is, they can disrupt the hormones of the human body, potentially increasing susceptibility to hormone-dependent cancers.
Frequent Usage is Risky:
The strongest association appeared to be among women who used chemical hair straighteners at least 4 times per year; researchers posit that year-after-year use of the product may significantly increase the risk of adverse health effects.
Weaknesses in the Study:
Although a statistical link was evident, it was impossible to establish direct causality in this study. The analysis relied on self-reported data from participants, and specific brands or ingredients responsible for these risks could not be pinpointed. Further research is ongoing in the area.
Symptoms & Medical Conditions
Symptoms of Uterine Cancer
One of the most frequent medical conditions mentioned in hair relaxer lawsuits is uterine cancer. Symptoms tend to develop slowly and can often be mistaken for other gynecological conditions. Anyone who experiences abnormal symptoms must seek medical attention to ensure proper treatment. Common symptoms of uterine cancer include:
- Abnormal vaginal bleeding, especially after menopause
- Bleeding between menstrual periods
- Pelvic pain or pressure
- Unusual vaginal discharge
- Pain during intercourse
- Frequent urination or trouble emptying your bladder
- Unexplained weight loss
- Constant fatigue
Ovarian Cancer Symptoms
Ovarian cancer has been nicknamed the “silent disease,” and the early signs can be vague and easy to overlook. Many women do not learn of their diagnosis until later stages of the disease. Common symptoms of ovarian cancer include:
- Constant bloating of the abdomen
- Pelvic or abdominal pain
- Feeling full quickly after eating
- Changes in bowel habits, such as constipation
- Frequent or urgent urination
- Unexplained weight loss
- Fatigue and lack of energy
- Back pain that won’t go away
Endometrial Cancer Symptoms
The cancer that occurs in the lining of the uterus is called endometrial cancer. It is one of the most diagnosed types of gynecologic cancer. Detecting symptoms of this illness early is key to successful treatment. Common symptoms of endometrial cancer include:
- Abnormal vaginal bleeding
- Bleeding occurring after menopause
- Heavier than normal or prolonged menstrual bleeding
- Pelvic pain or cramping
- Watery or bloody vaginal discharge
- Pain during sex
- Unexplained weight loss
- Weakness and fatigue in general
Fibroids and Endometriosis
Beyond cancerous conditions, many plaintiffs in hair relaxer litigation also state they have been diagnosed with uterine fibroids and endometriosis. These conditions can have severe effects on reproductive health and well-being.
Uterine Fibroids
Fibroids are noncancerous growths that can occur in and around the uterus. Symptoms may include:
Heavy menstrual bleeding
- Longer menstrual periods
- Pelvic pain or pressure
- Frequent need to urinate
- Lower back pain
- Pain during sexual intercourse
- Problems conceiving
Endometriosis
Endometriosis is a disorder in which tissue that resembles the uterine lining begins to grow outside of the uterus. Endometriosis is known for causing both discomfort and reproductive problems. Symptoms may include:
- Painful menstrual cramps
- Chronic pelvic pain
- Pain during and/or after sex
- Heavy menstrual bleeding
- Painful bowel movements
- Fatigue
- Infertility or difficulty conceiving
Why are these conditions so pertinent in the hair relaxer litigation?
Researchers have been studying whether prolonged exposure to certain chemicals in these hair products may be directly linked to hormone-related diseases like uterine cancer, ovarian cancer, endometrial cancer, fibroids, and endometriosis. Although the science is still developing, these health issues are most frequently mentioned within claims in the Federal hair relaxer litigation.
Health Risks of Dark and Lovely
The growing hair relaxer lawsuits have alleged that long-term use of Dark and Lovely and similar hair relaxing products causes serious damage to the reproductive system due to constant secretion of endocrine-disrupting chemicals. The major harms include –
- Uterine Cancer
- Ovarian Cancer
- Uterine fibroids and hysterectomy
- Endometrial Cancer
According to research, the endocrine-disrupting chemicals (EDCs) like parabens and phthalates block the body’s hormones, leading to cancer risk and damaged reproductive health. According to the National Institutes of Health’s Sister Study, the chances of developing uterine cancer are higher in women who regularly use chemical straighteners than in those who don’t.
How Chemical Relaxers Cause Cancer
Some chemical hair relaxers contain strong chemicals. The components include parabens, phthalates, and formaldehyde. When the scalp is burned or irritated, the chemicals can easily penetrate the skin. The more one uses the product, the more exposure they may have. The chemicals puzzle the body’s hormones. They affect how estrogen and progesterone work within the system. They may lead to abnormal cell growth in the uterus and other organs. According to some studies, there is a correlation between high cancer rates and frequent relaxer use. One of the studies affirmed that those who used relaxers as often as twice a week get uterine cancer. Given the research and studies, so many women filed the L’Oréal hair relaxer lawsuit after being diagnosed with cancer upon long-term usage of chemical hair relaxer.
Dark and Lovely Lawsuit Updates 2026 and MDL Status
Plaintiffs in the Dark and Lovely Lawsuit have alleged that the manufacturers knew the side effects and yet they marketed the products as safe. Women who have used Dark & Lovely for years have been diagnosed with uterine fibroids and uterine cancer. A group of hair relaxer plaintiffs filed a case in the JMPL, requesting that all hair relaxer lawsuits be consolidated into an MDL.
The Hair Relaxer MDL (No. 3060) was filed in February 2023 for pretrial proceedings in thousands of similar lawsuits nationwide. Judge Mary M. Rowland in the District Court for the Northern District of Illinois oversees the litigation. As of January 2026, the MDL has around 11,000 pending cases. All these cases have been filed against brands like Dark and Lovely, Just for Me, and Olive Oil Relaxers.
According to the lawsuits, the manufacturers scammed consumers by failing to disclose the risks of long-term chemical exposure. Research and reviews are ongoing. The bellwether trial is expected to shape future discussions on the L’Oréal hair relaxer lawsuit settlement. Our attorneys at People for Law are fighting in court, awaiting a ruling in the hair relaxer class action. L’Oréal has to disclose which chemicals are in the product.
Potential Settlement for Dark and Lovely Lawsuit
Our hair relaxer attorneys have assessed that a Dark & Lovely Lawsuit where uterine cancer is the primary injury can have a potential settlement between $300,000 and $1.75 million. The estimate is speculative and is based on several significant assumptions. One of those includes that the causation evidence is admissible in court. Contact our masstort attorneys if you have been in a similar situation because of Dark & Lovely usage.
The settlement range is wide, as uterine cancer cases present a number of circumstances. If the plaintiff has crossed the age of menopause, the case would get a low settlement offer, as uterine cancer has a considerable survival rate. If the plaintiff is comparatively young, the case is high-value due to treatment costs. Uterine cancer damages young women’s reproductive system and affects their ability to conceive. The cancer is somewhat aggressive in terms of its consequences.
L’Oréal hair relaxer lawsuit has been filed based on other injuries like uterine fibroids and endometriosis. These cases receive low settlement offers for two reasons. First, the evidence of causation linking the injuries to hair relaxers needs to be stronger. Second, the health conditions are not as severe as uterine cancer, which decreases the potential settlement value. Some of the robust cases in terms of human suffering have been those of uterine fibroids, and that’s reflected in the settlement amount for those claims.
Contact Our Attorneys to File a Dark & Lovely Lawsuit
Our lawfirm currently investigates product liability cases with allegations that chemicals in L’Oreal’s Dark & Lovely hair relaxer cause uterine cancer and breast cancer. If you think you are eligible to file a L’Oréal hair relaxer lawsuit against a chemical hair straightener, contact our attorneys for a case evaluation. If you or a loved one meets the criteria for the above product use and health conditions, legal options may be available to you. Request a free legal consultation with us.